NYSE:SYKStryker Stock Price, Forecast & News

Stryker's stock was trading at $175.62 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SYK shares have increased by 1.3% and is now trading at $177.89. View which stocks have been most impacted by Coronavirus.

26 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 2 sell ratings, 7 hold ratings, 16 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Stryker.

Stryker is scheduled to release its next quarterly earnings announcement on Thursday, July 30th 2020. View our earnings forecast for Stryker.

Stryker will be holding an earnings conference call on Thursday, July 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Stryker Co. (NYSE:SYK) announced its quarterly earnings data on Thursday, April, 30th. The medical technology company reported $1.84 EPS for the quarter, beating the consensus estimate of $1.69 by $0.15. The medical technology company had revenue of $3.59 billion for the quarter, compared to analyst estimates of $3.45 billion. Stryker had a net margin of 14.47% and a return on equity of 24.90%. The firm's revenue was up 2.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.88 earnings per share. View Stryker's earnings history.

Stryker announced a quarterly dividend on Tuesday, May 5th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.575 per share on Friday, July 31st. This represents a $2.30 annualized dividend and a dividend yield of 1.29%. The ex-dividend date is Monday, June 29th. View Stryker's dividend history.

26 brokerages have issued 12-month price objectives for Stryker's stock. Their forecasts range from $150.00 to $248.00. On average, they anticipate Stryker's share price to reach $215.20 in the next twelve months. This suggests a possible upside of 21.0% from the stock's current price. View analysts' price targets for Stryker.

Media stories about SYK stock have been trending neutral this week, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Stryker earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned media stories about the medical technology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news about Stryker.

Stryker saw a drop in short interest during the month of June. As of June 15th, there was short interest totaling 3,130,000 shares, a drop of 24.0% from the May 31st total of 4,120,000 shares. Based on an average daily trading volume, of 2,390,000 shares, the short-interest ratio is presently 1.3 days. Approximately 0.9% of the company's shares are short sold. View Stryker's Current Options Chain.

Some companies that are related to Stryker include Abbott Laboratories (ABT), Medtronic (MDT), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Insulet (PODD), Steris (STE) and Masimo (MASI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Walt Disney (DIS), Medtronic (MDT), Johnson & Johnson (JNJ), Home Depot (HD), AbbVie (ABBV), Abbott Laboratories (ABT), Visa (V), Alibaba Group (BABA), Bank of America (BAC) and NVIDIA (NVDA).

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Stryker's stock is owned by a number of retail and institutional investors. Top institutional shareholders include LGT Capital Partners LTD. (0.10%), Confluence Investment Management LLC (0.09%), Envestnet Asset Management Inc. (0.08%), Whittier Trust Co. (0.05%), Chesley Taft & Associates LLC (0.04%) and Capital Investment Services of America Inc. (0.03%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell and Yin C Becker. View institutional ownership trends for Stryker.

SYK stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Private Trust Co. NA, Addenda Capital Inc., Chesley Taft & Associates LLC, Stonebridge Capital Management Inc., Whittier Trust Co., Diversified Trust Co, and Abner Herrman & Brock LLC. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, M Kathryn Fink, Srikant M Datar, and Timothy J Scannell. View insider buying and selling activity for Stryker.

SYK stock was bought by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Park National Corp OH, American National Bank, LGT Capital Partners LTD., Carnegie Capital Asset Management LLC, Canandaigua National Corp, Legacy Private Trust Co., and Fulton Bank N. A.. View insider buying and selling activity for Stryker.

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SYK stock can currently be purchased for approximately $177.89.

Stryker has a market capitalization of $66.68 billion and generates $14.88 billion in revenue each year. The medical technology company earns $2.08 billion in net income (profit) each year or $8.26 on an earnings per share basis. Stryker employs 40,000 workers across the globe.

The official website for Stryker is www.strykercorp.com.

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]